Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy

被引：0
|
作者：
Mi Rim Choi
Craig A. Solid
Victoria M. Chia
Anne H. Blaes
John H. Page
Richard Barron
Thomas J. Arneson
机构：
[1] Amgen Inc.,Chronic Disease Research Group
[2] Minneapolis Medical Research Foundation,Division of Hematology/Oncology/Transplantation
[3] University of Minnesota,undefined
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Granulocyte colony-stimulating factor; G-CSF; Elderly cancer patients; G-CSF patterns of use; Supportive care; Treatment patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1619 / 1628
页数：9
相关论文
共 50 条
  • [1] Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy
    Choi, Mi Rim
    Solid, Craig A.
    Chia, Victoria M.
    Blaes, Anne H.
    Page, John H.
    Barron, Richard
    Arneson, Thomas J.
    SUPPORTIVE CARE IN CANCER, 2014, 22 (06) : 1619 - 1628
  • [2] Patterns of granulocyte colony stimulating factor (G-CSF) use in elderly breast cancer (BC) patients receiving myelosuppressive chemotherapy
    Blaes, A. H.
    Chia, V.
    Solid, C.
    Page, J.
    Barron, R. L.
    Choi, M. R.
    Arneson, T. J.
    CANCER RESEARCH, 2012, 72
  • [3] Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
    Gawade, Prasad L.
    Li, Shuling
    Henry, David
    Smith, Nancy
    Belani, Rajesh
    Kelsh, Michael A.
    Bradbury, Brian D.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (09) : 4413 - 4424
  • [4] Patterns of Granulocyte Colony-Stimulating Factor (G-CSF) Use in Elderly Patients with Non-Hodgkin's Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy
    Page, John H.
    Solid, Craig
    Chia, Victoria M.
    Blaes, Anne Hudson
    Barron, Richard L.
    Choi, Mi Rim
    Arneson, Thomas J.
    BLOOD, 2012, 120 (21)
  • [5] Meta-analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) in cancer patients receiving chemotherapy
    Kuderer, NM
    Crawford, J
    Dale, DC
    Lyman, GH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 758S - 758S
  • [6] Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy
    Schenfeld, Jennifer
    Gong, TingTing
    Henry, David
    Kelsh, Michael
    Gawade, Prasad
    Peng, Yi
    Bradbury, Brian D.
    Li, Shuling
    SUPPORTIVE CARE IN CANCER, 2022, 30 (07) : 6327 - 6338
  • [7] Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy
    Jennifer Schenfeld
    TingTing Gong
    David Henry
    Michael Kelsh
    Prasad Gawade
    Yi Peng
    Brian D. Bradbury
    Shuling Li
    Supportive Care in Cancer, 2022, 30 : 6327 - 6338
  • [8] Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
    Prasad L. Gawade
    Shuling Li
    David Henry
    Nancy Smith
    Rajesh Belani
    Michael A. Kelsh
    Brian D. Bradbury
    Supportive Care in Cancer, 2020, 28 : 4413 - 4424
  • [9] Evaluating the appropriateness of granulocyte colony-stimulating factor (G-CSF) use in patients (pts) receiving myelosuppressive chemotherapy by febrile neutropenia (FN) risk level.
    Baig, Hassam
    Klippel, Zandra Karina
    Pirolli, Melissa A.
    Somlo, Barbara
    Eisen, Melissa
    Stryker, Scott
    Tzivelekis, Spiros
    Morrow, Phuong Khanh H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis
    Ibanez, L.
    Sabate, M.
    Ballarin, E.
    Puig, R.
    Vidal, X.
    Laporte, J. -R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (03) : 224 - 228
12345